Table of Contents

company-logo

Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. The company was incorporated in 2016 and is based in Nedlands, Australia.

Neurotech International Dividend Announcement

• Neurotech International does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Neurotech International dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Neurotech International Dividend History

Neurotech International Dividend Yield

Neurotech International current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Neurotech International stock? Use our calculator to estimate your expected dividend yield:

Neurotech International Financial Ratios

P/E ratio-10.28
PEG ratio-0.10
P/B ratio4.38
ROE-60.73%
Payout ratio0.00%
Current ratio38.81
Quick ratio38.81
Cash Ratio6.71

Neurotech International Dividend FAQ

Does Neurotech International stock pay dividends?
Neurotech International does not currently pay dividends to its shareholders.
Has Neurotech International ever paid a dividend?
No, Neurotech International has no a history of paying dividends to its shareholders. Neurotech International is not known for its dividend payments.
Why doesn't Neurotech International pay dividends?
There are several potential reasons why Neurotech International would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Neurotech International ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Neurotech International has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Neurotech International a dividend aristocrat?
Neurotech International is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Neurotech International a dividend king?
Neurotech International is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Neurotech International a dividend stock?
No, Neurotech International is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Neurotech International stocks?
To buy Neurotech International you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Neurotech International stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.